Published by
@ShahidNShah
@ShahidNShah
Canvas Dx has the potential to facilitate early diagnosis in children with ASD
Canvas Dx is a software as a medical device (SaMD) that has been authorized by the FDA to aid physicians in diagnosing autism spectrum disorder (ASD) in young children. This technology utilizes clinically validated artificial intelligence (AI) to assist in the diagnosis of ASD in children between the ages of 18 and 72 months who are at risk of developmental delay. The diagnostic process involves a parent/caregiver questionnaire, which is collected via a parent/caregiver facing app, two videos of the child interacting in their natural environment, recorded by the caregiver and analyzed by a specially-trained video analyst, and an HCP questionnaire completed by a physician who meets with the child and a parent/caregiver, collected via a healthcare provider portal.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Media LLC. All Rights Reserved.
Built on Apr 26, 2024 at 6:14am